CDSCO supports foundations to direct clinical preliminaries in COVID-19 Patients Kumar Jeetendra | April 18, 2020 The Central Drugs Standard Control Organization (CDSCO) has given a green sign to intrigued foundations to direct the clinical preliminary with gaining strength plasma in COVID-19 patients, according to the convention created by Indian Council of Medical Research (ICMR). In a notification in regards to the clinical preliminary of healing plasma in COVID-19 patients, the …
myUpchar starts delivering Hospital Supplies for Health workers Kumar Jeetendra | April 27, 2020 Personal protective equipment (PPE) protects healthcare workers and caregivers who come in contact with COVID-19 patients again and again, and for prolonged periods. Globally, there is a shortage of this equipment as healthcare systems in many countries are under unprecedented strain because of the new coronavirus infection. Seeing the shortage of PPE equipment in several …
Indian doctors go online to treat patients in the midst of coronavirus flare-up Kumar Jeetendra | May 29, 2020 As India’s wellbeing framework thinks about the coronavirus, specialists are progressively going on the web to talk with patients enduring less basic or ceaseless maladies, while the south Asian economy gets ready to rise up out of an across the nation lockdown. To take off a surge at centers and a going with danger of …
Amid Covid-19 Lockdown, Doctors at Aster CMI Hospital Conduct Life Saving Liver Transplant of a 4-year-old child Kumar Jeetendra | May 29, 2020 Bangalore, May 28, 2020: At a time when healthcare workers across the country are donning protective gear to deal with the COVID-19 crisis, a team of medical staffs at Aster CMI Hospital suited up on April 13, 2020 to deliver a life-saving liver transplant for 4-year-old Raghavi from Vellore who was suffering from advanced liver …
Pfizer, BioNTech’s coronavirus immunizations get FDA’s ‘most optimized plan of attack’ status Kumar Jeetendra | July 13, 2020 The candidates, both BNT162b1 and BNT162b2, would be the most complex of at least four vaccines getting analyzed by most firms in ongoing trials in the United States and Germany. Pfizer’s shares were up roughly 2% and U.S.-listed stocks of BioNTech were up roughly 6 percent before the bell. Earlier this month, the firms said …
Biocon’s accomplice Equillium plans Itolizumab’s worldwide clinical preliminary for COVID-19 Kumar Jeetendra | July 13, 2020 Biocon’s partner Equillium has said it is planning to conduct a global randomised controlled clinical trial of Itolizumab in COVID-19 patients, for the American biotech firm will record a US investigational new drug application (IND). Itolizumab, which is used for the treatment of psoriasis, is repurposed for COVID-19, as it regulates the production of inflammatory …
Phase 2 preliminary discovers Chinese COVID-19 antibody is sheltered, incites insusceptible reaction: Lancet study Kumar Jeetendra | July 21, 2020 A phase II clinical trial of a COVID-19 vaccine candidate, conducted in China, has found it is safe and causes an immune reaction, a study published in The Lancet says. Researchers, for example those from the Center for Disease Control and Prevention, said the trial sought to assess the safety and immunogenicity of this vaccine …
Coronavirus immunization engineers promise decent variety in clinical preliminaries Kumar Jeetendra | July 21, 2020 Drugmakers racing to develop a safe and efficient coronavirus vaccine pledged on Tuesday to ensure their clinical trials could consist of varied sets of volunteers. In prepared remarks for a U.S. congressional hearing, several companies pledged to include broad representation as they prepare to start studies with tens of thousands of volunteers from the coming …
US signs contract with Pfizer for COVID-19 antibody dosages Kumar Jeetendra | July 22, 2020 Wellbeing and Human Services Secretary Alex Azar declared on Wednesday that the US has marked an agreement with Pfizer for conveyance in December of the initial 100 million dosages of a COVID-19 antibody the pharmaceutical organization is attempting to create. The US could purchase another 500 million portions under the understanding, Azar said. “Presently those …
High-dosage favipiravir ‘strong’ against COVID-19, HCQ totally incapable: Study Kumar Jeetendra | October 11, 2020 Research conducted at the KU Leuven Rega Institute in Belgium has found that the antimalarial drug hydroxychloroquine (HCQ) doesn’t limit the multiplication of the novel coronavirus. However, a very high dose of the flu drug favipiravir does have antiviral efficacy, according to their results. The researchers gave the hamsters either hydroxychloroquine or favipiravir for four …
India sees early vaccine dispatch as AstraZeneca conveyances run late Kumar Jeetendra | November 6, 2020 A vaccine is seen as the world’s best bet for taming a virus that has infected more than 48 million people, led to over 1.2 million deaths, roiled markets and disrupted countless lives because it was first identified in China in December. Australia is beefing up its potential arsenal against the pandemic to 135 million …
India near offering reimbursement to foreign vaccine creators like Pfizer: Report Kumar Jeetendra | June 10, 2021 India is close to agreeing to grant foreign COVID-19 vaccine makers such as Pfizer Inc protection against legal liability so that it can use their shots in an immunisation campaign that is facing acute shortages, three government sources told Reuters. “Indemnity will be granted,” said one of the sources. “If one company gets it then …
